References
- Clinical safety data management: Definition and standards for expedited reporting E2A (ICH E2A). (1994). International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. Available at http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E2A/Step4/E2A_Guideline.pdf
- Development Safety Update Report E2F (ICH E2F). (2010). International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. Available at: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E2F/Step4/E2F_Step_4.pdf
- Dodsworth, N. (2009). GCP discussion: pregnancy of research subject’s partner. CR Focus, 20: 27–28.
- Food and Drug Administration (FDA). (2010). Code of Federal Regulations Title 21. Sec. 312.32 IND safety reports. Available at http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?FR=312.32
- Food and Drug Administration (FDA). (2010b). Guidance for Industry and Investigators: Safety Reporting Requirements for IND and BA/BE studies. Draft guidance. Available at http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM227351.pdf
- Guideline for good clinical practice E6 (ICH GCP E6). (1996). International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. Available at http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/E6_R1_Guideline.pdf
- International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH E2F). (2006). Final concept paper: E2F-development safety update report. Available at http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E2F/Concept_papers/E2F_Concept_Paper.pdf